argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
26 may 2020 - 07:00
Statutory name
argenx SE
Title
argenx Announces Positive Topline Results from Phase 3 ADAPT Trial of Efgartigimod in Patients with Generalized Myasthenia Gravis
Date last update: 22 June 2026